RFG Bristol Wealth Advisors LLC Buys New Position in Colgate-Palmolive (NYSE:CL)

RFG Bristol Wealth Advisors LLC bought a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,180 shares of the company's stock, valued at approximately $289,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Meeder Advisory Services Inc. boosted its position in Colgate-Palmolive by 9.0% during the 4th quarter. Meeder Advisory Services Inc. now owns 20,483 shares of the company's stock valued at $1,862,000 after purchasing an additional 1,688 shares during the period. Groupama Asset Managment increased its holdings in shares of Colgate-Palmolive by 127.2% in the 4th quarter. Groupama Asset Managment now owns 31,767 shares of the company's stock worth $2,884,000 after acquiring an additional 17,788 shares during the period. Alliance Wealth Management Group lifted its position in Colgate-Palmolive by 73.0% in the 4th quarter. Alliance Wealth Management Group now owns 4,981 shares of the company's stock valued at $453,000 after purchasing an additional 2,101 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Colgate-Palmolive by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company's stock valued at $1,868,723,000 after purchasing an additional 324,683 shares during the period. Finally, Tradewinds LLC. boosted its position in shares of Colgate-Palmolive by 9.8% during the fourth quarter. Tradewinds LLC. now owns 63,831 shares of the company's stock worth $5,539,000 after buying an additional 5,705 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. UBS Group lowered their price target on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Friday. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an "overweight" rating in a research report on Friday, March 14th. Finally, Barclays boosted their target price on Colgate-Palmolive from $83.00 to $89.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 27th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $102.06.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded down $2.68 during midday trading on Monday, reaching $88.98. 2,711,774 shares of the company's stock were exchanged, compared to its average volume of 4,526,568. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock's 50-day simple moving average is $90.27 and its 200 day simple moving average is $93.13. The firm has a market cap of $72.17 billion, a price-to-earnings ratio of 25.17, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company earned $0.87 earnings per share. On average, analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has authorized a stock buyback plan on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.34%. Colgate-Palmolive's payout ratio is presently 59.09%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.